Sorrento Therapeutics Inc. et al v. Hui Li et al: First Amended Complaint

First Amended Complaint in Sorrento Therapeutics Inc., of Delaware, and Levena Suzhou Biopharma Co. Ltd., of China v. Hui Li and Adcentrx Therapeutics Inc., both of California, at the Superior Court of the State of California, County of San Diego.

Pages: 90

Date: November 23, 2021

Plaintiffs/Applicants: Sorrento Therapeutics Inc., Levena Suzhou Biopharma Co. Ltd.

Case Number: Xx Xx Xx

Defendants/Respondents: Hui Li, Adcentrx Therapeutics Inc.

Plaintiffs/Applicants Attorneys: Robert Ellison

Topics

Keywords

Adcentrx Therapeutics Hui Li Levena Suzhou Biopharma Sorrento Therapeutics

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.

Sorrento Therapeutics Inc. et al v. Hui Li et al: First Amended Complaint

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.

Related Content

Topics

Keywords

Related Content

Sorrento Therapeutics Inc. et al v. Hui Li et al: Complaint